Yeruusaalem, 22 Janaayo, 2026 (TPS-IL) — Shirkad cusub oo Israa’iili ah oo samaysa qalabka caafimaadka, Trisol Medical, ayaa shaacisay natiijooyin wanaagsan oo ka soo baxay daraasad hore oo la oggolaaday FDA oo lagu sameeyay nidaamkeeda beddelka xubnaha wadnaha ee saddexda geesoodka ah ee loo yaqaan ‘transcatheter tricuspid valve replacement system’ oo loogu talagalay bukaanada qaba xanuunka daran ee saddexda geesoodka ah ee wadnaha.
Shirkadda oo fadhigeedu yahay Yokneam ayaa sheegtay in 22 bukaan oo halis sare leh lagu daaweeyay xarumo caafimaad oo waaweyn oo Maraykanka ah, taasoo muujisay qaab-dhismeedka badqabka ah iyo horumar weyn oo shaqo. 30 maalmood ilaa 12 bilood, bukaanku waxay muujiyeen yaraansho daadashada xubnaha wadnaha, horumar ku yimid tayada nolosha, xaalad wanaagsan oo wadne-xanuun ah, iyo horumar ku yimid shaqada galka midig ee wadnaha. Wax ka yar 5 boqolkiiba waxay u baahdeen qalab joogto ah oo wadnaha garaaca.
Trisol waxay dhammaystirtay diiwaangelinta iyadoo isticmaalaysa habka ‘trans-jugular’ waxaana ay sii waddaa diiwaangelinta iyadoo isticmaalaysa nidaam cusub oo la sameeyay oo loo yaqaan ‘transfemoral delivery system’.